Literature DB >> 15222326

Input virion proteins: cryptic targets of antivector immune responses in preimmunized subjects.

Pedro R Lowenstein1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15222326     DOI： 10.1016/j.ymthe.2004.05.019

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  7 in total

Review 1.  Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.

Authors:  Pedro R Lowenstein; Ronald J Mandel; Wei-Dong Xiong; Kurt Kroeger; Maria G Castro
Journal:  Curr Gene Ther       Date:  2007-10       Impact factor: 4.391

Review 2.  Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

Authors:  Ronald J Mandel; Corinna Burger; Richard O Snyder
Journal:  Exp Neurol       Date:  2007-08-24       Impact factor: 5.330

3.  Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.

Authors:  Carmen S Peden; Fredric P Manfredsson; Sharon K Reimsnider; Amy E Poirier; Corinna Burger; Nicholas Muzyczka; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-01-13       Impact factor: 11.454

4.  Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response.

Authors:  L Samaranch; P Hadaczek; A P Kells; J R Bringas; D Stockinger; W San Sebastian; M Macayan; S Samineni; P Pivirotto; J Forsayeth; K S Bankiewicz
Journal:  Gene Ther       Date:  2015-08-23       Impact factor: 5.250

5.  Immune regulation of transgene expression in the brain: B cells regulate an early phase of elimination of transgene expression from adenoviral vectors.

Authors:  Jeffrey M Zirger; Chunyan Liu; Carlos Barcia; Maria G Castro; Pedro R Lowenstein
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

6.  Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses.

Authors:  Evelyn Abordo-Adesida; Antonia Follenzi; Carlos Barcia; Sandra Sciascia; Maria G Castro; Luigi Naldini; Pedro R Lowenstein
Journal:  Hum Gene Ther       Date:  2005-06       Impact factor: 5.695

7.  Gene therapy for Parkinson's disease.

Authors:  Rachel Denyer; Michael R Douglas
Journal:  Parkinsons Dis       Date:  2012-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.